Skip to main content
. Author manuscript; available in PMC: 2012 Mar 18.
Published in final edited form as: J Clin Oncol. 2008 Feb 11;26(8):1331–1337. doi: 10.1200/JCO.2007.13.9626

Table 5.

Hazard Ratio for the Development of Invasive ER-Positive and ER-Negative Breast Cancer After RRSO

Technique No. of Patients ER-Positive Invasive Breast Cancer ER-Negative Invasive Breast Cancer
Events Hazard Ratio 95% CI P Events Hazard Ratio 95% CI P
RRSO 300 2 0.22 0.05 to 1.05 .058 14 1.10 0.48 to 2.51 .85
Surveillance 284 7 1.0 Referent 11 1.0 Referent

Abbreviations: ER, estrogen receptor; RRSO, risk-reducing salpingo-oophorectomy.